Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid
出版年份 2023 全文链接
标题
Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid
作者
关键词
-
出版物
Molecular Cancer
Volume 22, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-11-06
DOI
10.1186/s12943-023-01864-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
- (2022) J. Pascual et al. ANNALS OF ONCOLOGY
- A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)
- (2022) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating tumour DNA — looking beyond the blood
- (2022) Ann Tivey et al. Nature Reviews Clinical Oncology
- Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer
- (2021) Bonnita Werner et al. GYNECOLOGIC ONCOLOGY
- Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in Ovarian Cancer
- (2020) Mi-Ryung Han et al. Cancer Research and Treatment
- ShallowHRD: detection of homologous recombination deficiency from shallow whole genome sequencing
- (2020) Alexandre Eeckhoutte et al. BIOINFORMATICS
- Epithelial ovarian cancer
- (2019) Stephanie Lheureux et al. LANCET
- Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2019) Antonio González-Martín et al. NEW ENGLAND JOURNAL OF MEDICINE
- Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
- (2019) Robert L. Coleman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
- (2019) Isabelle Ray-Coquard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Next-generation sequencing reveals mutational accordance between cell-free DNA from plasma, malignant pleural effusion and ascites and directs targeted therapy in a gastric cancer patient
- (2018) Shujuan Zhou et al. CANCER BIOLOGY & THERAPY
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2018) Kathleen Moore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology
- (2017) Hatim Husain et al. MOLECULAR CANCER THERAPEUTICS
- Origins, structures, and functions of circulating DNA in oncology
- (2016) A. R. Thierry et al. CANCER AND METASTASIS REVIEWS
- Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer
- (2015) P. A. Konstantinopoulos et al. Cancer Discovery
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started